Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
CRACW
Valuation N/A
Crown Reserve Acquisition Corp. I
Price$0.03
Model IV—
P/IV—
Limited data — see page
CRAN
Valuation N/A
Crane Harbor Acquisition Corp. II
Price$10.10
Model IV—
P/IV—
Limited data — see page
CRANR
Valuation N/A
Crane Harbor Acquisition Corp. II
Price$0.16
Model IV—
P/IV—
Limited data — see page
CRANU
Valuation N/A
Crane Harbor Acquisition Corp. II
Price$10.31
Model IV—
P/IV—
Limited data — see page
CRAQ
Valuation N/A
Cal Redwood Acquisition Corp.
Price$10.41
Model IV—
P/IV—
Limited data — see page
CRAQR
Valuation N/A
Cal Redwood Acquisition Corp.
Price$0.18
Model IV—
P/IV—
Limited data — see page
CRAQU
Valuation N/A
Cal Redwood Acquisition Corp.
Price$10.74
Model IV—
P/IV—
Limited data — see page
CRBU
Valuation N/A
Caribou Biosciences, Inc.
Price$0.46
Model IV—
P/IV—
Market implies +47.7%/yr
vs model +3.8% · above model
CRDF
Valuation N/A
Cardiff Oncology, Inc.
Price$1.08
Model IV—
P/IV—
Market implies +75.5%/yr
vs model +13.4% · above model
CRDL
Valuation N/A
Cardiol Therapeutics Inc.
Price$1.23
Model IV—
P/IV—
Limited data — see page
CRE
Deeply undervalued
Cre8 Enterprise Ltd
Price$2.86
Model IV$42.11
P/IV0.06
Discount 93%
Return to IV: +1,372.2%
Market implies -20.0%/yr
vs model +24.5% · below model
CREG
Valuation N/A
Smart Powerr Corp.
Price$0.18
Model IV—
P/IV—
Market implies -50.0%/yr
vs model +12.0% · below model
CREX
Deeply undervalued
CREATIVE REALITIES, INC.
Price$2.38
Model IV$28.53
P/IV0.13
Discount 92%
Return to IV: +1,098.7%
Market implies -50.0%/yr
vs model +32.7% · below model
CRF
Valuation N/A
CORNERSTONE TOTAL RETURN FUND INC
Price$6.22
Model IV—
P/IV—
Limited data — see page
CRGO
Deeply overvalued
Freightos Ltd
Price$0.84
Model IV$0.38
P/IV2.71
Premium +120%
Return to IV: -54.5%
Market implies +10.9%/yr
vs model +27.6% · below model
CRGOW
Valuation N/A
Freightos Ltd
Price$0.02
Model IV—
P/IV—
Market implies -37.5%/yr
vs model +27.6% · below model
CRIS
Valuation N/A
CURIS INC
Price$0.67
Model IV—
P/IV—
Market implies +19.9%/yr
vs model +2.0% · above model
CRMLW
Valuation N/A
Critical Metals Corp.
Price$2.18
Model IV—
P/IV—
Market implies +55.3%/yr
vs model +5.0% · above model
CRMT
Valuation N/A
AMERICAS CARMART INC
Price$1.35
Model IV—
P/IV—
Market implies -50.0%/yr
vs model +9.4% · below model
CRNT
Deeply overvalued
CERAGON NETWORKS LTD
Price$2.16
Model IV$1.65
P/IV1.28
Premium +31%
Return to IV: -23.7%
Market implies +9.6%/yr
vs model +9.6% · in line
CRT
Valuation N/A
CROSS TIMBERS ROYALTY TRUST
Price$11.94
Model IV—
P/IV—
Limited data — see page
CRTO
Deeply undervalued
Criteo S.A.
Price$15.73
Model IV$38.26
P/IV0.11
Discount 59%
Return to IV: +143.2%
Market implies -9.4%/yr
vs model +6.9% · below model
CRVO
Valuation N/A
CervoMed Inc.
Price$3.22
Model IV—
P/IV—
Market implies +24.0%/yr
CRWS
Deeply undervalued
CROWN CRAFTS INC
Price$2.39
Model IV$10.37
P/IV0.28
Discount 77%
Return to IV: +333.7%
Market implies -21.9%/yr
vs model +4.1% · below model
CSAI
Deeply overvalued
CLOUDASTRUCTURE, INC.
Price$2.59
Model IV$0.91
P/IV0.54
Premium +185%
Return to IV: -65.0%
Market implies +18.2%/yr
vs model +50.0% · below model
CSBR
Deeply undervalued
CHAMPIONS ONCOLOGY, INC.
Price$4.84
Model IV$11.38
P/IV0.51
Discount 57%
Return to IV: +135.2%
Market implies -5.3%/yr
vs model +9.5% · below model
CSHRW
Valuation N/A
CoinShares PLC
Price$0.79
Model IV—
P/IV—
Limited data — see page
CSPI
Undervalued
CSP INC /MA/
Price$7.36
Model IV$9.10
P/IV0.85
Discount 19%
Return to IV: +23.6%
Market implies -4.9%/yr
vs model +4.5% · below model
CSTE
Fairly valued
Caesarstone Ltd.
Price$2.85
Model IV$2.64
P/IV0.70
Premium +8%
Return to IV: -7.2%
Market implies -0.1%/yr
vs model +2.0% · in line
CSTL
Deeply undervalued
CASTLE BIOSCIENCES INC
Price$34.42
Model IV$70.42
P/IV0.07
Discount 51%
Return to IV: +104.6%
Market implies -16.0%/yr
vs model +38.3% · below model
CSUI
Valuation N/A
CANNABIS SUISSE CORP.
Price$0.01
Model IV—
P/IV—
Market implies +60.0%/yr
CTAA
Valuation N/A
Clearthink 1 Acquisition Corp.
Price$9.99
Model IV—
P/IV—
Limited data — see page
CTAAR
Valuation N/A
Clearthink 1 Acquisition Corp.
Price$0.20
Model IV—
P/IV—
Limited data — see page
CTAAU
Valuation N/A
Clearthink 1 Acquisition Corp.
Price$10.07
Model IV—
P/IV—
Limited data — see page
CTM
Deeply overvalued
Castellum, Inc.
Price$0.62
Model IV$0.31
P/IV2.70
Premium +98%
Return to IV: -49.5%
Market implies +14.1%/yr
vs model +20.5% · below model
CTNT
Deeply overvalued
CHEETAH NET SUPPLY CHAIN SERVICE INC.
Price$2.64
Model IV$0.53
P/IV0.08
Premium +396%
Return to IV: -79.8%
Market implies +24.5%/yr
vs model +6.0% · above model
CTOR
Valuation N/A
CITIUS ONCOLOGY, INC.
Price$0.84
Model IV—
P/IV—
Limited data — see page
CTRA
Valuation N/A
CTRA
Price$32.56
Model IV—
P/IV—
Limited data — see page
CTRM
Deeply overvalued
Castor Maritime Inc.
Price$1.70
Model IV$0.91
P/IV2.09
Premium +87%
Return to IV: -46.6%
Market implies -2.3%/yr
vs model -7.0% · above model
CTSO
Valuation N/A
Cytosorbents Corp
Price$3.79
Model IV—
P/IV—
Market implies +29.8%/yr
vs model +2.0% · above model
CTW
Deeply undervalued
CTW Cayman
Price$2.30
Model IV$6.38
P/IV0.39
Discount 64%
Return to IV: +177.5%
Market implies -21.9%/yr
vs model +19.8% · below model
CTXR
Valuation N/A
Citius Pharmaceuticals, Inc.
Price$0.50
Model IV—
P/IV—
Market implies +51.6%/yr
CUBWU
Valuation N/A
Lionheart Holdings
Price$11.02
Model IV—
P/IV—
Limited data — see page
CUBWW
Valuation N/A
Lionheart Holdings
Price$0.10
Model IV—
P/IV—
Limited data — see page
CUE
Valuation N/A
Cue Biopharma, Inc.
Price$27.66
Model IV—
P/IV—
Market implies +90.7%/yr
vs model +16.4% · above model
CULP
Deeply undervalued
CULP INC
Price$3.67
Model IV$8.50
P/IV0.36
Discount 57%
Return to IV: +131.5%
Market implies -20.5%/yr
vs model +2.0% · below model
CUPR
Valuation N/A
Cuprina Holdings (Cayman) LTD
Price$1.69
Model IV—
P/IV—
Market implies +99.4%/yr
CURI
Deeply undervalued
CuriosityStream Inc.
Price$2.80
Model IV$9.33
P/IV0.31
Discount 70%
Return to IV: +233.3%
Market implies -21.4%/yr
vs model +50.0% · below model
CURR
Valuation N/A
Currenc Group Inc.
Price$2.72
Model IV—
P/IV—
Market implies +15.5%/yr
vs model -3.4% · above model
CURV
Deeply undervalued
Torrid Holdings Inc.
Price$2.54
Model IV$9.28
P/IV0.17
Discount 73%
Return to IV: +265.4%
Market implies -27.5%/yr
vs model +2.0% · below model
CURX
Valuation N/A
Curanex Pharmaceuticals Inc
Price$5.31
Model IV—
P/IV—
Limited data — see page
CVAT
Deeply undervalued
Cavitation Technologies, Inc.
Price$0.03
Model IV$0.08
P/IV0.51
Discount 60%
Return to IV: +150.0%
Market implies -25.0%/yr
vs model +5.0% · below model
CVGI
Undervalued
Commercial Vehicle Group, Inc.
Price$2.87
Model IV$3.38
P/IV1.52
Discount 15%
Return to IV: +17.9%
Market implies -6.8%/yr
vs model +0.0% · below model
CVKD
Valuation N/A
Cadrenal Therapeutics, Inc.
Price$0.91
Model IV—
P/IV—
Limited data — see page
CVLT
Valuation N/A
COMMVAULT SYSTEMS INC
Price$157.25
Model IV—
P/IV—
Market implies +24.9%/yr
vs model +12.9% · above model
CVM
Valuation N/A
CEL SCI CORP
Price$1.94
Model IV—
P/IV—
Limited data — see page
CVR
Deeply overvalued
CHICAGO RIVET & MACHINE CO
Price$11.20
Model IV$8.03
P/IV1.25
Premium +39%
Return to IV: -28.3%
Market implies +4.4%/yr
vs model +2.0% · in line
CVRX
Deeply undervalued
CVRx, Inc.
Price$1.58
Model IV$10.57
P/IV0.53
Discount 85%
Return to IV: +569.2%
Market implies -37.9%/yr
vs model +44.4% · below model
CVU
Deeply overvalued
CPI AEROSTRUCTURES INC
Price$5.14
Model IV$2.64
P/IV1.98
Premium +95%
Return to IV: -48.7%
Market implies +5.6%/yr
vs model +2.0% · above model
CVV
Valuation N/A
CVD EQUIPMENT CORP
Price$4.18
Model IV—
P/IV—
Market implies +39.9%/yr
